Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX ...

ABT stock surges 21.7% year to date on CGM sales growth and robust diagnostics demand, even as FX and macro risks weigh on forecasts.

The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device ...

The healthcare sector is an ideal place for long-term investors to focus their attention, in my view. You won't need a ...

Abbott's mixed reality technology helps distract blood donors and reduce their anxiety levels. This can help encourage young ...

According to Abbott, there is a pressing need for a continuous glucose-ketone monitor for individuals who are at higher risk of developing ketoacidosis.

Abbott and Beta Bionics are collaborating to integrate Abbott’s upcoming dual glucose-ketone sensor with Beta’s iLet Bionic ...

An all-inclusive approach to diabetes management becomes key—one that includes staying active indoors, eating mindfully, and keeping up with glucose monitoring ... CGM devices like FreeStyle Libre ...

The global continuous glucose monitoring device market is estimated to be valued at USD 12,690.7 million in 2025 and is projected to reach USD 54,553.1 million by 2035, registering a CAGR of 15.7% ...

For patients with type 2 diabetes (T2D), disparities in continuous glucose monitor (CGM) prescriptions are seen by language ...

Efficient blood sugar control plays a major role in preventing diabetes, a disease affecting millions around the world. Detecting problems early, though, has always been tough.

After a meal some people experience high spikes in blood sugar followed by a crashing low. The dips can cause fatigue, moodiness and lead to overeating. Learning how to manage your blood sugar can ...